AQN three-lens brief
Evidence-based stock research on AQN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.86% yesterday. · Trading at 6% of its 52-week range — deep in the lower band.
- Moved -2.86% yesterday.
- Trading at 6% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 12.8pp over 30 days.
- Analyst mean target $6.75 — 24% above current (10 analysts).
AQN closed at $5.43 (-2.86%) as of 2026-09-11. Market cap: $4.18B. P/E (trailing) 23.6. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $6.75 — 24% above current (10 analysts).. Concerns: moved -2.86% yesterday.; trading at 6% of its 52-week range — deep in the lower band.. Last quarter: Revenue $543.90M, net income $4.90M, free cash flow -$80.99M.
Why three lenses on AQN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AQNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AQN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AQN brief"></iframe>